Testosterone propionate is a slower-releasing anabolic steroid with a short half-life. It is a synthetic androstane steroid derivative of testosterone in the form of 17β propionate ester of testosterone. Testosterone propionate was developed initially by Watson labs, and FDA approved on February 5, 1974. Currently, this drug has been discontinued in humans, but the vet application is still available as an OTC.
1.原发性或继发性男性性功能低减;2.绝经后女性晚期乳腺癌的姑息性治疗;男性青春期发育迟缓。
Robert Josephs, Austin, Texas, United States
Fletcher Allen Health Care, University of Vermont, Burlington, Vermont, United States
Memorial Hospital of Rhode Island,, Pawtucket, Rhode Island, United States
Sheba Medical Center, Psychiatric out patient clinical unit, Tel Hashomer, Israel
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.